COMPANY

ExeGi Pharma

Profile checked Oct 10, 2026

Keywords: Ileal Pouch EXE-346

Timeline

Nov 6, 2023 Trial start Phase 1/Phase 2: Study of EXE-346 Live Biotherapeutic to Reduce High Bowel Movement Frequency in Subjects With an IPAA (PROF) source ↗

May 31, 2027 (ESTIMATED) · Phase 1/Phase 2 · Study of EXE-346 Live Biotherapeutic to Reduce High Bowel Movement Frequency in Subjects With an IPAA (PROF) · NCT05938465

Estimated primary completion per ClinicalTrials.gov. Dates move.

Record	Title	Phase	Status	Start	Primary completion
NCT05938465	Study of EXE-346 Live Biotherapeutic to Reduce High Bowel Movement Frequency in Subjects With an IPAA (PROF)	Phase 1/Phase 2	Recruiting	Nov 6, 2023	May 31, 2027 (estimated)